Thomas Marsland
Overview
Explore the profile of Thomas Marsland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McAneny B, Marsland T, King K
J Oncol Pract
. 2018 Feb;
5(6):301-304.
PMID: 29436267
A discussion of two compelling topics at this summer's Hematology-Oncology Carrier Advisory Committee Network Meeting: coverage for off-label uses of anticancer drugs and medical necessity for oral versus intravenous antiemetics.
2.
3.
Kabbinavar F, Fehrenbacher L, Hainsworth J, Kasubhai S, Kressel B, Marsland T, et al.
J Thorac Oncol
. 2014 Aug;
9(9):1411-7.
PMID: 25122437
Introduction: ATLAS compared bevacizumab plus erlotinib (B+E) with bevacizumab plus placebo (B+P) as maintenance therapy after first-line bevacizumab plus chemotherapy (B+C) for advanced non-small-cell lung cancer (NSCLC). Prespecified biomarkers were...
4.
Marsland T, Schuur E
Case Rep Oncol
. 2014 May;
7(1):175-81.
PMID: 24803895
Management of metastatic breast cancer is critical to maximizing survival with good quality of life. Circulating tumor cell (CTC) levels in the peripheral blood hold promise for enabling improved patient...
5.
Johnson B, Kabbinavar F, Fehrenbacher L, Hainsworth J, Kasubhai S, Kressel B, et al.
J Clin Oncol
. 2013 Oct;
31(31):3926-34.
PMID: 24101054
Purpose: This phase III trial was performed to assess the potential benefit of adding maintenance erlotinib to bevacizumab after a first-line chemotherapy regimen with bevacizumab for advanced non-small-cell lung cancer...
6.
McCaskill-Stevens W, Lyss A, Good M, Marsland T, Lilenbaum R
Am Soc Clin Oncol Educ Book
. 2013 May;
PMID: 23714464
Research in the community setting is essential for the translation of advances in cancer research into practice and improving cancer care for all populations. The National Cancer Institute is proposing...
7.
Marsland T, Arena F, Yeilding A, Glode M, Ellis L, Yu J, et al.
Oncology (Williston Park)
. 2012 Jan;
25(12):1183, 1187-8, 1190.
PMID: 22229211
No abstract available.
8.
Marsland T, Robbins G, Marks A, Cassell R, Philips D, King K
J Oncol Pract
. 2011 Jan;
6(5):265-9.
PMID: 21197194
One of Florida's largest private payers has retained an outside consulting firm to develop a program to reduce cancer care spending, which could seriously limit the ability of oncology practices...
9.
OShaughnessy J, Vukelja S, Marsland T, Kimmel G, Ratnam S, Pippen J
Clin Breast Cancer
. 2004 Jul;
5(2):142-7.
PMID: 15245619
We evaluated the efficacy and toxicity of trastuzumab plus gemcitabine in patients with HER2-positive metastatic breast cancer (MBC). Sixty-four patients were enrolled, the majority of whom (95%) had been treated...
10.